Steinert Tilman, Hirsch Sophie
Klinik für Psychiatrie und Psychotherapie I, Zentrum für Psychiatrie Südwürttemberg, Universität Ulm (Weissenau), Weingartshoferstr. 2, 88214, Ravensburg, Deutschland.
Interdisziplinäre Sektion für Neuroonkologie, Departments für Neurologie und Neurochirurgie, Hertie-Institut für Klinische Hirnforschung, Universitätsklinikum Tübingen, Eberhard-Karls-Universität Tübingen, Tübingen, Deutschland.
Nervenarzt. 2020 Jul;91(7):611-616. doi: 10.1007/s00115-019-00801-2.
This article reports on the developmental process, significance and scope of clinical practice guidelines and presents changes to the former S2 guidelines on therapeutic interventions for aggressive behavior (2010). Aggressive behavior is understood both in the context of risk characteristics on the patient side and as a result of escalating conflicts between patients and staff. If coercive measures are unavoidable, they must be carried out in the most bearable and humane way possible for all participants. For the first time these guidelines provide clear evidence-based and consensus-based recommendations for these issues. In addition to prevention, de-escalation, rapid tranquilization and pharmacotherapy of acute states of agitation and of recurrent aggressive behavior, technical, legal and ethical aspects of coercive measures and therapeutic support during coercive measures are covered. Further recommendations concern measures of tertiary prophylaxis, such as debriefing, joint crisis plans and external monitoring by visiting commissions and political committees. Implementation recommendations have been formulated from the guidelines. They are currently being tested in a pilot study funded by the German Association for Psychiatry, Psychotherapy and Psychosomatics (DGPPN).
本文报告了临床实践指南的制定过程、意义和范围,并介绍了先前关于攻击行为治疗干预的S2指南(2010年)的变化。攻击行为既被理解为患者方面的风险特征,也被视为患者与工作人员之间冲突升级的结果。如果强制措施不可避免,必须以对所有参与者来说最可承受和人道的方式实施。这些指南首次为这些问题提供了明确的基于证据和共识的建议。除了预防、降级、快速镇静以及对急性激越状态和反复出现的攻击行为进行药物治疗外,还涵盖了强制措施的技术、法律和伦理方面以及强制措施期间的治疗支持。进一步的建议涉及三级预防措施,如汇报、联合危机计划以及由来访委员会和政治委员会进行外部监督。已根据这些指南制定了实施建议。目前正在由德国精神病学、心理治疗和身心医学协会(DGPPN)资助的一项试点研究中对其进行测试。